Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Risperidone; Serotonin uptake inhibitors
- Indications Depressive disorders
- Focus Therapeutic Use
- 30 Mar 2017 Planned End Date changed from 1 Dec 2006 to 1 Mar 2006.
- 27 Aug 2007 Status changed from in progress to withdrawn. The study was withdrawn prior to recruitment due to failed recruitment efforts.
- 10 Aug 2006 Status change